Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer's Disease on April 12, 2024 -April 01, 2024 at 07:31 am EDT

NEW YORK, April 01, 2024 -- Cognition Therapeutics, Inc. , a clinical stage company developing drugs that treat neurodegenerative disorders, today announced it will host a virtual KOL event on...

Related Keywords

United States ,Amsterdam ,Noord Holland ,Netherlands ,Poland ,Iceland ,American ,Casey Mcdonald ,Anton Porsteinsson ,Martinj Sadowski ,Mike Moyer ,Jort Vijverberg ,Henrym Wisniewski ,Research In Dr ,University Of Amsterdam ,York University School Of Medicine ,Alzheimer Association ,American Federation For Aging Research ,School Of Medicine ,Company Or Cognition ,Cognition Therapeutics Inc ,National Institute On ,University Of Iceland School Medicine ,University Of Rochester Alzheimer Disease Care ,Paulb Beeson Career Development Award ,Tiberend Strategic Advisors Inc ,University Of Rochester ,Alzheimer Center Amsterdam ,Globenewswire Inc ,University Of Rochester Memory Care Program ,Securities Exchange Commission ,Education Program ,University Of Gdansk ,National Institutes Of Health ,Amsterdam Alzheimer Center At Neuroscience ,Rochester Alzheimer ,Disease Care ,York University School ,Konar Professor ,Rochester Memory Care Program ,Iceland School ,Aging Research ,Career Development Award ,Gdansk Poland ,Amsterdam Alzheimer Center ,Amsterdam Neuroscience ,Universiteit Amsterdam ,Brain Project ,Leiden Universiteit ,Private Securities Litigation Reform Act ,Exchange Commission ,Strategic Advisors ,Markets ,